Complete NXTC Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
NXTC Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 9 peer companies in Healthcare
P/E Ratio
$-18.12
-3951.4%
Peer Median: 10.2x
EV/EBITDA
$0.00
-100.0%
Peer Median: 1.2x
P/S Ratio
$0.00
-100.0%
Peer Median: 0.5x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for NXTC's business model and current situation.
Multiple Comparison
| Multiple | NXTC Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -0.3x | 10.2x | 5.6x | -102.6% | Undervalued |
| EV/EBITDA | -Infinityx | 1.2x | 1.2x | -Infinity% | Undervalued |
| P/S Ratio | Infinityx | 0.5x | 5.2x | Infinity% | Overvalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.01B | 0.0x | 0.0x | 239.9x | |
| $0.01B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 1.0x | 1.2x | 0.2x | |
| $0.01B | 0.0x | 0.0x | 0.5x | |
| $0.01B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 10.2x | -15.2x | 31.6x | |
| $0.01B | 0.0x | 0.0x | 34.3x | |
| $0.01B | 0.0x | 0.0x | 36.9x | |
| $0.01B | 0.0x | 0.0x | 15.1x |